Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

Schedule of Equity Compensation Plan Information

Equity Compensation Plan Information as of March 31, 2026:

	Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)		Weighted – average exercise price of outstanding options, warrants and rights (b)		Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) (c)
Equity Compensation Plans Approved by Security Holders		3,150,000	$	0.0399		21,680,882
Equity Compensation Plans Not Approved by Security Holders		37,801,503		0.0195		—
Total		40,951,503	$	0.0297		21,680,882

Schedule of Valuation Assumptions of Options

The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

	Three Months ended March 31,
	2026			2025
Expected volatility	172.0% - 346.4		%	172.0 – 346.4		%
Expected term		.5 –4. Years			1.5 – 5.0 Years
Risk-free interest rate		0.16% - 4.64	%		0.16% - 4.64	%
Forfeiture rate		0.17	%		0.17	%

Schedule of Outstanding Stock Option Activity

A summary of the status of the Company’s outstanding stock options as of March 31, 2026 and December 31, 2025 and changes during the periods ending on such dates is as follows:

	Number of			Weighted Average Exercise		Weighted Average Remaining Contractual		Aggregate Intrinsic
	Options			Price		Life in Years		Value
Outstanding at December 31, 2025		238,439,167		$	0.0362		1.43
Granted		-			-
Forfeited		(170,999,530	)		0.0379
Exercised		-			-
Cancelled					-
Outstanding – December 31, 2025		67,439,637		$	0.0360		1.43
Exercisable – December 31, 2025		41,057,753		$	0.0211		1.33	$	-
Granted		-			-
Forfeited		(1,475,000	)		0.0379
Exercised		-			-
Expired		(35,295,237	)
Cancelled		-			-
Outstanding – March 31, 2026		30,669,400		$	0.043268		1.07
Exercisable –March 31, 2026		7,059,400		$	0.0531		1.106	$	-

Schedule of Exercise Price of Employee Stock Options Outstanding

The following table summarizes information about employee stock options outstanding at March 31, 2026.

Range of Exercise Price	Number outstanding at March 31, 2026		Weighted average remaining Life		Weighted average exercise price		Number exercisable at March 31, 2026		Weighted average exercise price		Weighted average remaining life
$ 0.0180 - $0.0225 (Expired)		0		0.00	$	0.0180		0.00	$	0.0180		0.00
$ 0.0229 - $0.0325		50,000		1.12	$	0.0302		50,000	$	0.0302		.37
$ 0.0360 - $0.0425		22,659,400		1.05	$	0.0398		4,659,400	$	0.0395		.33
$ 0.0440 - $0.0531		7,960,000		1.17	$	0.0531		2,350,000	$	0.0530		.42
Outstanding options		30,669,400		1.07	$	0.0432		7,059,400	$	0.0439		0.36

Schedule of Warrant Activity

A summary of the Company’s warrants as of December 31, 2025 and changes during the three months ended March 31, 2026 is presented below:

	Number of		Weighted Average Exercise		Weighted Average Remaining Contractual		Aggregate Intrinsic
	Warrants		Price		Life in Years		Value
Outstanding – December 31, 2025		25,684,521	$	0.0247		0.93	$	24,000
Granted		-		-		-		-
Exercised
Forfeited or Expired		25,684,521		0.0247		0.93		24,000
Outstanding – March 31, 2026		0	$	0		0		0
Exercisable – March 31, 2026		0	$	0		0	$	0